Graham Holdings Company

Fundamentals7.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Improving margins
  • Cash flow volatility
  • Moderate leverage

AI
AI Summary

6.0

Graham Holdings should be reframed as a diversified, cash-generative holding whose investment upside hinges on management converting lumpy, accrual-driven operating cash flow into consistent FCF to fund buybacks/deleveraging and accretive healthcare roll-ups—monitor quarterly NCFO volatility, receivables/deferred-revenue collectability, and integration metrics as the specific catalysts/risks.

CashFlow
ExecutionRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Improving margins
  • Cash flow volatility
  • Moderate leverage

GHC shows improving margins and manageable leverage but uneven quarterly cash flow and heavy intangibles that warrant monitoring.

MarginMomentum
IntangibleRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Short-term downtrend
  • At last-month low
  • Failed reclaim attempts

GHC is in a short-term downtrend—closing at $1036.87 below last month's average (~$1061) and sitting at last-month low near $1036 with downside momentum unless it reclaims $1060–$1075.

bearish
watch
Support Level: $1036 (primary) and $1045–$1055 (secondary)
Resistance Level: $1061 and $1077–$1095

Drop from $1094.66 on 2026-02-20 to $1036.87 on 2026-03-20 over last month signals strong downside momentum

Sentiment & News

7.0

Key News Insights:

  • Revenue up 3%
  • Dividend declared
  • Covenant acquisition

Graham Holdings posted 2025 revenue of $4.91B (+3%) driven by education, healthcare and manufacturing, declared a $1.88 quarterly dividend, expanded healthcare with the Covenant acquisition, and noted TV declines and an institutional stake reduction.

DividendGrowth

Modest organic growth and a strategic healthcare buy bolster cash flow and dividend support, but TV weakness and reduced institutional interest may limit near-term upside